CAS 154947-66-7
:LL-37
Description:
LL-37 is a human cathelicidin antimicrobial peptide (CAMP) that plays a crucial role in the innate immune response. It is composed of 37 amino acids and is known for its broad-spectrum antimicrobial activity against various pathogens, including bacteria, fungi, and viruses. LL-37 exhibits a unique amphipathic structure, allowing it to interact with and disrupt microbial membranes, leading to cell lysis. Additionally, it possesses immunomodulatory properties, influencing inflammation and wound healing processes. LL-37 is produced by various cells, including neutrophils and epithelial cells, and is found in various tissues, particularly during infection or injury. Its ability to promote angiogenesis and modulate immune responses makes it a subject of interest in therapeutic research, particularly in the context of chronic wounds and infections. Overall, LL-37 is a vital component of the host defense system, contributing to the maintenance of skin and mucosal integrity.
- H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH
- antibacterial protein LL-37 amide
- LL-37(human)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
LL-37
CAS:LL-37 is an antimicrobial peptide with angiogenic activity. It corresponds to the C-terminal sequence (134-170) of the human cathelicidin antimicrobial protein hCAP18/LL-37 and is extracellularly released from hCAP18/LL-37 by proteolytic processing. hCAP18/LL-37 is an effector of the innate immune system and is expressed in leukocytes and epithelial cells where it is upregulated in association with inflammation and injury. An overexpression of hCAP18/LL-37 in a series of breast carcinomas could be demonstrated. LL-37 has been suggested to stimulate epithelial cell proliferation partially through formyl peptide receptor-like 1 (FPRL1) since blocking the receptor with pertussis toxin decreased the proliferative effect of LL-37 by approximately 50 %.Formula:C205H340N60O53Purity:96.7%Color and Shape:WhiteMolecular weight:4493.33LL-37, Human
CAS:<p>LL-37, Human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity.</p>Formula:C205H340N60O53Purity:98%Color and Shape:SolidMolecular weight:4493.26LL-37 ( Human)
CAS:<p>LL-37 is a 37 amino acid peptide that is produced by neutrophils and other leukocytes. This peptide has been shown to have anti-inflammatory properties, which may be due to its ability to bind and activate the G protein coupled receptor (GPCR) formyl peptide receptor-like 1 (FPRL1), leading to inhibition of the production of inflammatory mediators such as IL-8. LL-37 also binds to ion channels, which may lead to membrane depolarization, thereby blocking calcium influx into the cell. LL-37 has been shown to inhibit the activation of T cells by inhibiting T cell receptor signaling and reducing cytokine production.<br>LL-37 also has a high affinity for antibody binding sites on B cells and macrophages and can bind with high specificity to IgE on mast cells, leading to inhibition of mast cell degranulation. The binding of LL-37 with these receptors leads to reduced inflammation in tissues, which may</p>Formula:C205H340N60O53Purity:Min. 95%Molecular weight:4,493.3 g/molCathelicidin LL 37
CAS:<p>LL-37 is a potent antimicrobial peptide that has been shown to be effective against cancer cells and is currently being investigated as a potential antineoplastic agent. LL-37 binds to the leukocyte receptor, which leads to chemotaxis, increased expression of p53 and apoptosis. LL-37 also induces apoptotic cell death in epithelial tissues, both in vitro and in vivo. This peptide has been shown to induce death in cancer cells, as well as cell death in other types of cells.</p>Formula:C205H340N60O53Purity:Min. 95%Molecular weight:4,493.27 g/mol
